EsoCap is developing a novel smart drug delivery technology enabling targeted and long-lasting local therapy of the esophagus for the first time. Our business model is to demonstrate the clinical feasibility in one indication, (EoE), and to enter into a transaction with a major partner.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2017
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in